Podcasts about priti krishtel

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/priti_krishtel_why_are_drug_prices_so_high_investigating_the_outdated_us_patent_system ■Post on this topic (You can get FREE learning materials!) https://englist.me/127-academic-words-reference-from-priti-krishtel-why-are-drug-prices-so-high-investigating-the-outdated-us-patent-system--ted-talk/ ■Youtube Video https://youtu.be/xs00KPu4Kf4 (All Words) https://youtu.be/WxXNIicLd3I (Advanced Words) https://youtu.be/0MGpqa6q2xg (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

Original broadcast date: November 12, 2021. We hear calls for systemic change, but what does that look like? This hour, TED speakers share stories of taking on institutions — from schools, to medicine, to policing — so they work for everyone. Guests include economist Emily Oster, lawyer Priti Krishtel and social psychologist Phillip Atiba Goff.

Original broadcast date: November 12, 2021. We hear calls for systemic change, but what does that look like? This hour, TED speakers share stories of taking on institutions — from schools, to medicine, to policing — so they work for everyone. Guests include economist Emily Oster, lawyer Priti Krishtel and social psychologist Phillip Atiba Goff.

Millions of lives are at risk worldwide because of unjust systems that prevent those who are most vulnerable from getting the medicines they need. Even in the U.S., structural inequities exist and remain prevalent, despite appeals for their elimination. In this episode, Priti Krishtel, a health justice lawyer and Co-Founder and Co-Executive Director of the non-profit organization I-MAK, shares how her organization advances solutions to address structural inequity in the medicines system through research, education, and policy. “I think in the U.S. we have a real problem now. And that's why so many people are speaking out to say prescription drugs should not be priced this high,” says Priti Krishtel. Among the highlights in this episode: 1:40: Listener comment 2:39: Twitter is no longer enforcing its COVID misinformation policy 3:50: “Misinformation that spreads on the internet, particularly a place like Twitter, can reach millions of people in a matter of seconds, let alone minutes and days, and influential people who have influence over others, people who are respected and looked up to, start to spread this misinformation as well,” says Steven Newmark, Director of Policy at GHLF 4:13: GHLF has developed a free program for patients and their families to access updated and verified information, community support, and other resources tailored specifically to their health and safety. You can enroll in the program here: https://ghlf.org/coronavirus-patient-support/ 5:08: In a recent statement, the National Institutes of Health (NIH) noted that COVID-19 subvariants are likely to be resistant to Evusheld, a preventive COVID treatment for people who are immunocompromised 5:56: As treatments like Evusheld become less powerful in preventing COVID-19, other measures like getting the new bivalent vaccine booster are even more crucial for immunocompromised patients 6:06: December 1 through December 7 marks Crohn's and Colitis Awareness Week 8:06: Priti Krishtel shares what drew her to found I-MAK and describes the mission of the organization 9:33: “We were working in the Global South… in middle income countries that have really huge populations living in poverty… And there we saw a lot of wins,” says Priti Krishtel. “But then in about 2015, we started getting calls from the United States because you know, prescription drugs spending, I think, has increased about 60% over the last 10 years in the U.S.” 12:22: I-MAK's Participatory Changemaking tool (PCM) and an explanation of how it brings together members of affected communities as well as leaders from government, academia, and the private sector to create new thinking about the future of the patent system 14:21: Priti Krishtel shares a memorable patient interaction and its impact on her 17:09: To learn more about what's happening with patent reform, you can sign up for I-MAK's newsletter at i-mak.org 17:39: What our hosts learned from this episode Contact Our Hosts Steven Newmark, Director of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Associate Director, Community Outreach at GHLF: zrothblatt@ghlf.org We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to thehealthadvocates@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

You've heard the stories and seen the headlines – life-saving drugs can be so expensive, people have to choose between them and buying food or paying rent. Oakland's Priti Krishtel is working on a solution to this terrifying problem – she wants to reform the patent system. Pharmaceutical companies hold patents on their products, creating an ongoing monopoly that prevents competitors from bringing cheaper medications to the market to drive prices down. We'll talk with Krishtel, who was recently awarded a MacArthur grant, about how she got into health justice and how she plans to update the patent system to bring equity to the medical system and save lives. Guests: Priti Krishtel, health justice lawyer and co-founder and co-executive director Organization: I-MAK. - a non-profit building a more just and equitable medicines system. She is also a 2022 MacArthur fellow.

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to existing ones, which allows them to build monopolies, block competition and drive prices up. Health justice lawyer Priti Krishtel sheds light on how we've lost sight of the patent system's original intent -- and offers five reforms for a redesign that would serve the public and save lives. After the talk, our host Modupe dives into a recent example of how the US is rethinking patents.

Priti Krishtel - Health justice lawyer and co-founder of I-MAK, a non-profit building a more just and equitable medicines system. She has spent nearly two decades exposing structural inequities affecting access to medicines and vaccines across the Global South and in the United States. In observance of World Health Day today, she will join Tavis to discuss the structural discriminations affecting access to medicines and vaccines across the United States and what methods we have at our disposal to combat these inequities

We hear calls for systemic change, but what does that look like? This hour, TED speakers share stories of taking on institutions — from schools, to medicine, to policing — so they work for everyone. Guests include economist Emily Oster, lawyer Priti Krishtel, and social psychologist Phillip Atiba Goff.

While rich countries are doling out booster shots of the COVID-19 vaccine, many poor countries have vaccinated less than five percent of their population. And, while many leaders agree that vaccinating the world is the only way out of the pandemic, vaccines are still not moving around the globe in a rapid and equitable manner. This is because “we live in a hierarchy of health,” says Priti Krishtel, a health justice lawyer and cofounder of I-MAK, a nonprofit focused on building a more just and equitable medicines system. On the latest episode of The Dose, Krishtel argues that unequal access to vaccines is rooted in a long-standing system of incentives that governs drug development and allocation. She says rethinking the drug patent regime and other incentives — and working together to ensure every country gets a fair allocation of vaccines — is the way to end this and future pandemics.

Priti Krishtel started her career working with low-income communities in India where she saw her clients suffering, and even dying, because they couldn't afford the lifesaving medicines they needed. Now, she is advocating for a more equitable healthcare system in the U.S. and around the world. She gives us her Brief But Spectacular take on the importance of building a system that works for all. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Priti Krishtel started her career working with low-income communities in India where she saw her clients suffering, and even dying, because they couldn't afford the lifesaving medicines they needed. Now, she is advocating for a more equitable healthcare system in the U.S. and around the world. She gives us her Brief But Spectacular take on the importance of building a system that works for all. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

America's first medical patents date back to the 1790s—and patents still inform our every prescription, vaccine, and pharmacy run. This week on Getting Curious, Priti Krishtel joins Jonathan to break down the basics on medical patents. Why do they exist? Who do they serve? And how equitable are they?  Priti Krishtel is a health justice lawyer and co-founder of I-MAK, a non-profit building a more just and equitable medicines system. She has spent nearly two decades exposing structural inequities affecting access to medicines and vaccines across the Global South and in the United States. You can follow Priti on Twitter @pritikrishtel. I-MAK is on Twitter @IMAKglobal and at i-mak.org. Find out what today's guest and former guests are up to by following us on Instagram and Twitter @CuriousWithJVN.Transcripts for each episode are available at JonathanVanNess.com.Check out Getting Curious merch at PodSwag.com.Listen to more music from Quiñ by heading over to TheQuinCat.com.Jonathan is on Instagram and Twitter @JVN and @Jonathan.Vanness on Facebook.

America's first medical patents date back to the 1790s—and patents still inform our every prescription, vaccine, and pharmacy run. This week on Getting Curious, Priti Krishtel joins Jonathan to break down the basics on medical patents. Why do they exist? Who do they serve? And how equitable are they?   Priti Krishtel is a health justice lawyer and co-founder of I-MAK, a non-profit building a more just and equitable medicines system. She has spent nearly two decades exposing structural inequities affecting access to medicines and vaccines across the Global South and in the United States.   You can follow Priti on Twitter @pritikrishtel. I-MAK is on Twitter @IMAKglobal and at i-mak.org.   Find out what today's guest and former guests are up to by following us on Instagram and Twitter @CuriousWithJVN. Transcripts for each episode are available at JonathanVanNess.com. Check out Getting Curious merch at PodSwag.com. Listen to more music from Quiñ by heading over to TheQuinCat.com. Jonathan is on Instagram and Twitter @JVN and @Jonathan.Vanness on Facebook.

As Covid-19 continues to sweep the world and most countries, especially in the Global South, struggle to access vaccines, Radical Imagination takes a fresh look at how the US patent system keeps billions of people at home and abroad from obtaining life-saving medicines. Since our first episode on this topic, early in the pandemic, the situation has become more dire. In India, one of the world's largest vaccine producers, almost nobody had access to the Covid vaccine last spring, when the virus began tearing through the country. The idea behind patents is to allow companies to protect the time and money they invest in developing drugs and vaccines. In reality, companies profit astronomically while people die because they can't afford or obtain treatment.  Host Angela Glover Blackwell speaks with lawyer and activist Priti Krishtel, a leader of a global movement to change the patent system and ensure access to medicine for all. We also hear from Leena Menghaney, South Asia head of the Doctors Without Borders Access Campaign.

Listen Now Last October India and South Africa appealed to the World Trade Organization to temporarily waive patent or intellectual...

Getting the right medicine at the right time can mean the difference between life or death. Yet until COVID-19, there hasn't been widespread recognition of the importance of creating easy and equitable access to life-saving medications. That's where Priti Krishtel comes in. While the pandemic has arguably accelerated a movement around global access to medicines, she's spent the last 20 years working to uncover how the patent system prevents life-saving drugs from getting into the hands of people who need them most. Priti is a health justice lawyer and co-founder of Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit working to address structural inequities in how medicines are developed and distributed. She investigates the outdated patent system and uses law to challenge big pharma, corporations, and a general economic structure driven by profit. Her earlier career experience working on the HIV/AIDS crisis in India gives her a deep sense of purpose in tackling an issue that, for many, has newfound importance in the Coronavirus Era. Courtney talks with Priti about how she's working to sustain the access to medicine movement so that when the next pandemic hits, fewer people die.For show notes and transcripts go to https://skoll.org/2021/06/02/a-patent-detective-investigates-access-to-medicine/ On social media: @skollfoundation #solverspod Send us an email: solvers@skoll.org

We’re asking: is racism silently shaping the global vaccine response? And what could President Biden’s recent huge decision to take on vaccine monopolies mean for people around the world? We also do a special round of “big pharma bingo”, examining the key arguments that pharmaceutical corporations have been making that is stifling the mass production of Covid-19 vaccines. Max and Nabil are joined by three giants from the access to medicines and public health movement: Priti Krishtel and Tahir Amin (the Co-Executive Directors of IMAK, which challenges systemic injustice and advocates for health equity in drug development and access), and Asia Russell (the CEO of HealthGAP, which is dedicated to ensuring that all people living with HIV have access to life-saving medicines). Come to learn, to find inspiration, and to get the inside track on the vaccine issue. More information about the people’s vaccine is at www.peoplesvaccine.org This is the first episode of the EQUALS podcast, season four. And if you’re joining us for the first time, tune in to our earlier interviews – from talking with the award-winning journalist Gary Younge on what we can learn from Martin Luther King Jr to fight inequality, to best-selling author Anand Giridharadas on whether we need billionaires, Zambian music artist PilAto on the power of music, thinker Ece Temelkuran on beating fascism, climate activist Hindou Ibrahim on nature, and the Managing Director of the International Monetary Fund Kristalina Georgieva on what comes after the pandemic. See acast.com/privacy for privacy and opt-out information.

On May 5, the US government decided to throw its weight behind an increasingly-popular WTO measure: waiving intellectual property protections for COVID vaccines. But what is this waiver? And what could it actually mean for people looking to get inoculated? We explain how seemingly-arcane trade negotiations came to mean life and death for the billions of people waiting on a vaccine. In this episode:Public health activists Achal Prabhala of accessibsa and Priti Krishtel @pritikrishtel of I-MAK @IMAKglobal.Connect with The Take: Twitter (@AJTheTake), Instagram (@ajthetake) and Facebook (@TheTakePod)

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to existing ones, which allows them to build monopolies, block competition and drive prices up. Health justice lawyer Priti Krishtel sheds light on how we've lost sight of the patent system's original intent -- and offers five reforms for a redesign that would serve the public and save lives.

You may have heard that poorer countries across the globe are not going to have access to the COVID-19 vaccine for a loooong time. If you live in a rich country, why should that matter to you? The short answer: because the pandemic can't truly end in one place if it doesn't end in all places. Oh, and also because it's the right thing to do.  Today on the podcast, we welcome back guest Priti Krishtel, co-founder and co-executive director of global medicine access organization, I-MAK. Priti has been working for nearly two decades in the movement to create a more equitable and just medicine system for all, and COVID-19 is the perfect case study for why I-MAK's mission is to fix the broken patent system that keeps affordable drugs out of reach for so many.  Today on the podcast, we discuss the process countries undertake to secure vaccine supplies for their citizens and how that money-driven process advantages richer countries while disadvantaging poorer ones. Priti talks about existing global efforts to create vaccine equity, and how they have fallen short due to the greed of both pharma companies AND countries like the US. We also dive into how our antiquated customs around patents and intellectual property in pharmaceuticals create a huge hindrance to addressing a global pandemic with any useful speed, and why that will hurt ALL of us in the long run. Lastly, Priti discusses the lessons we can learn from other countries' handling of the pandemic, and particularly countries in the Global South, and what's ahead in the fight for global, equitable access to medicines. [NOTE: This interview was recorded on February 16, 2021. Details of the progress of global vaccine deployment may have changed slightly between the recording date and this podcast's release date in late March 2021, but broad themes remain the same.] Resources: - Priti's New York Times Op-Ed: How the Patent and Trademark Office Can Promote Racial Justice  - The Overwhelming Racism Of COVID Coverage by Indi Samarajiva

Cui Tiankai, Chinese Ambassador to the U.S., calls CNN's reporting on Uyghur children separated from their families and kept from leaving China's Xinjiang region "immoral" and a "fabrication" in a wide ranging conversation with Christiane Amanpour. Joe Parkinson, co-author of "Bring Back Our Girls", discusses the kidnapping of nearly 300 Chibok schoolgirls in 2014 and the agency and solidarity that bonded them. Our Hari Sreenivasan talks to Priti Krishtel, Co-Founder and Executive Director of Initiative for Medicines, Access & Knowledge, about vaccine nationalism and why we need to rethink how patents are regulated. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Episode 4 is the final episode of ACCESS In episode 4 we discuss the ‘race' to find a vaccine for COVID-19 – a vaccine that is available to everyone who needs it. Our expert guests consider global and local developments, vaccine trials, and the politics fueling what is being referred to as the COVID 19 ‘vaccine wars' or ‘vaccine nationalism' - which may hinder access over time. Our expert guests are: · Dr Linda-Gail Bekker is a hji Reference Group Advisory Member, researcher, clinician and public health advocate, COO of the Desmond Tutu HIV Foundation and Director of the Desmond Tutu HIV Centre. · Priti Krishtel is a co-founder and co-director of I-MAK, and a lawyer and medicine access activist, and campaigner for justice. She is also a community organiser, and advocate for patients. · Safura Abdool-Karim is a public health lawyer, senior researcher at Priceless-SA and an Aspen New Voices 2020 Fellow. · Lukhona Mnguni is a political analyst and commentator and PhD intern researcher at the Maurice Webb Race Relations Unit at the University of KwaZula Natal. Presented by Fatima Hassan. Produced by the Health Justice Initiative and Volume.

Entre 2006 et 2016, le nombre de brevets pharmaceutiques déposés aux États-Unis a doublé, mais pas à cause d'une poussée d'inventivité ou d'innovation. Les compagnies pharmaceutiques ont appris à contourner le système en cumulant les brevets, non pas pour de nouveaux médicaments, mais pour des changements mineurs apportés aux anciens, ce qui leur permet de se constituer des monopoles, d'éliminer toute concurrence et de faire gonfler les prix. Priti Krishtel, une avocate spécialisée dans les questions de justice sanitaire, fait la lumière sur la manière dont nous avons perdu de vue les intentions initiales du système de brevet, et propose un plan de refonte en cinq points pour servir l'intérêt général et sauver des vies.

You probably know about the gender wage gap, but have you ever thought about the gender health gap? Katie again welcomes to the podcast Priti Krishtel, co-founder and co-executive director of I-MAK, an organization using patent law to increase global access to medicines. Priti explains the ways in which women (yes, even you!) are disproportionately harmed by the high prices of drugs and healthcare, and what this means for us as we get older and need to rely more and more on the healthcare system. For example, did you know that a quarter of the twelve highest-grossing drugs in the US treat conditions that primarily affect women? This includes breast cancer drug Herceptin, which comes with a yearly price tag of over $60,000! Priti discusses the damage that high drug prices inflict on women's health, and how you (yes, even you!!) can take small steps to help lower drug prices for all. 

Katie speaks with Priti Krishtel, co-founder and co-executive director of I-MAK, an organization that uses patent law to fight high drug prices across the globe. Think patent law doesn't affect your life? Think again. Chances are, at some point in your life, you've been prescribed an expensive medication that did not have an affordable, generic equivalent. That's patent law at play. Priti discusses how pharmaceutical companies abuse the patent system to keep drug prices high, how it's possible to increase global access to affordable and life-saving medicines by restoring integrity to the patent system, and what YOU as a layperson can do to help bring drug prices down at home and abroad.